Three cases-one for the colon, a second in cardiology, and a third addressing the liver-will serve as the playing fields for this year’s Workstation Face-Off. Seven companies will go head to head Wednesday May 19 from 3:30 to 6 p.m. with luminaries putting their workstations through carefully choreographed steps.
Three cases-one for the colon, a second in cardiology, and a third addressing the liver-will serve as the playing fields for this year’s Workstation Face-Off. Seven companies will go head to head Wednesday May 19 from 3:30 to 6 p.m. with luminaries putting their workstations through carefully choreographed steps.
Vital Images will bring three physician-customers to champion their product; GE Healthcare will bring two . Philips, Siemens, Carestream, TeraRecon, and Ziosoft will each field just one operator. All operators will follow exactly the same instructions, demonstrating workflow and image quality on their respective workstations, all within the same four-minute time frame for each case.
Case 1 – Screening for colon polyps:
Case 2 – Aortic valvular stenosis as part of a preoperative evaluation:
Case 3 – Evaluation of a patient with metastatic cholangiocarcinoma on experimental treatment:
Rules of engagement prohibit the use of prerendering.
“No matter how fast you can switch from screen to screen to pick up on presaved views, the sophisticated audience can see what you are doing,” the rules advise.
If Face-Off moderator Dr. Geoffrey Rubin does as he has in the past, he will remind operators to fully magnify and zoom in on findings, a rule often overlooked under the time constraints of the demonstrations, time constraints that have been, and will be again this year, strictly enforced.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.